• Price to earnings forward of Pliant Therapeutics, Inc. – TRADEGATE:9PT TradingView Thu, 09 Jul 2026 19:53:11 GMT
• Enterprise value to EBITDA forward of Pliant Therapeutics, Inc. – NASDAQ:PLRX TradingView Sun, 05 Jul 2026 08:26:03 GMT
• enterprise value to ebit forward of pliant therapeutics, inc. – nasdaq:plrx TradingView Fri, 03 Jul 2026 01:15:22 GMT
• plrx financials: revenue breakdown, margins & competitor comparison Intellectia AI Tue, 30 Jun 2026 03:06:10 GMT
• pliant therapeutics inc (plrx) valuation: pe, pb & fair value analysis TradingKey Fri, 26 Jun 2026 06:19:03 GMT
• Pliant Therapeutics, Inc. Actuals & Estimates (NASDAQ:PLRX) TradingView Thu, 25 Jun 2026 18:58:23 GMT
• pliant therapeutics inc (plrx) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• pliant therapeutics inc (plrx) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• pliant therapeutics inc (plrx) valuation: pe, pb & fair value analysis TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• pliant therapeutics inc (plrx) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 22:53:51 GMT
• Pliant Therapeutics Inc (PLRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Wed, 17 Jun 2026 22:51:38 GMT
• pliant therapeutics inc (plrx) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 22:22:19 GMT
• pliant therapeutics inc (plrx) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 21:18:57 GMT
• pliant therapeutics inc (plrx) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 20:44:30 GMT
• pliant therapeutics inc (plrx) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 20:38:45 GMT
• pliant therapeutics inc (plrx) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 19:40:23 GMT
• pliant therapeutics inc (plrx) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 13:05:24 GMT
• pliant therapeutics inc (plrx) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• pliant therapeutics inc (plrx) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• pliant therapeutics inc (plrx) earnings forecast: future eps & revenue growth estimates TradingKey Mon, 15 Jun 2026 07:00:00 GMT
• plrx sec filings - pliant therapeutics, inc. 10-k, 10-q, 8-k forms Stock Titan Sat, 13 Jun 2026 05:04:48 GMT
• pliant therapeutics (plrx) director receives 70,000-share stock option grant Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• pliant (nasdaq: plrx) director awarded 70,000 stock options at $1.14 Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• pliant therapeutics (plrx) director granted 70,000 options at $1.14 strike Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• director darren cline receives 70,000 plrx stock options at $1.14 strike price Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• pliant therapeutics (nasdaq: plrx) reports 2026 director, pay and auditor votes Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• pliant therapeutics shareholders approve directors and executive pay TipRanks Thu, 11 Jun 2026 07:00:00 GMT
• pliant therapeutics to participate in the rbc capital markets global healthcare conference The Manila Times Thu, 04 Jun 2026 08:36:51 GMT
• primary sclerosing cholangitis market is projected to boom by 2034 owing to the launch of novel therapies | delveinsight Barchart.com Wed, 03 Jun 2026 07:00:00 GMT
• pliant therapeutics (plrx) inches higher: consolidation near support amid biotech sector volatility - accumulation line newsline.com Sat, 30 May 2026 07:00:00 GMT
• pliant therapeutics (plrx) holds near support amid modest gains, biotech sector weakness persists - naaim leverage The Legal Advocate Fri, 29 May 2026 14:42:07 GMT
• a quick look at today's ratings for pliant therapeutics(plrx.us), with a forecast between $2 to $3 富途牛牛 Fri, 29 May 2026 07:50:43 GMT
• pliant therapeutics (plrx) holds near support amid modest gains – key levels in focus - cash secured put newsline.com Thu, 28 May 2026 07:00:00 GMT
• plrx q1 2026 earnings: narrower-than-expected loss as clinical pipeline progresses - revenue estimate trend newsline.com Thu, 28 May 2026 07:00:00 GMT
• pliant therapeutics (plrx) edges higher as stock holds above key support - seasonality effect newsline.com Wed, 27 May 2026 07:00:00 GMT
• pliant drug aims to break cancer's resistance to immunotherapy BriefGlance Fri, 22 May 2026 08:38:54 GMT
• pliant therapeutics (plrx) faces selling pressure, testing key support at $1.15 - hidden order The Legal Advocate Fri, 22 May 2026 07:00:00 GMT
• pliant therapeutics to present phase 1b trial data of pln-101095 at asco 2026. Pluang Fri, 22 May 2026 05:34:14 GMT
• pliant therapeutics (plrx) bounces 2.5% as biotech tests key resistance - real trader insights Newser Fri, 22 May 2026 02:36:00 GMT
• global oncology researchers to review fortify data as pliant therapeutics joins asco meeting Traders Union Thu, 21 May 2026 23:07:01 GMT
• pliant drug aims to break cancer's resistance to immunotherapy BriefGlance Thu, 21 May 2026 23:02:30 GMT
• Pliant Therapeutics Announces Upcoming Presentation at the GlobeNewswire Thu, 21 May 2026 07:00:00 GMT
• pliant therapeutics (plrx) stock: consolidating at $1.20 — next move ahead 2026-05-21 - bollinger expansion newsline.com Thu, 21 May 2026 07:00:00 GMT
• pliant therapeutics to present phase 1b trial data of pln-101095 at asco 2026. Pluang Thu, 21 May 2026 07:00:00 GMT
• pliant therapeutics (plrx) q1 2026 earnings beat: revenue $n/a, eps $-0.32 - margin guidance newsline.com Thu, 21 May 2026 07:00:00 GMT
• pliant therapeutics inc at rbc capital markets global healthcare conference transcript GuruFocus Wed, 20 May 2026 04:53:58 GMT
• pliant therapeutics (plrx) delivers q1 2026 beat — eps $-0.32 vs $-0.36 expected - surprise factor analysis The Legal Advocate Tue, 19 May 2026 07:00:00 GMT
• atisama advances rb042 trial, appoints bernard coulie as chair Investing.com UK Fri, 15 May 2026 15:44:33 GMT
• atisama therapeutics advances rb042 into multiple ascending dose cohorts of phase 1 trial and appoints bernard coulie as chair of ... Financial Times Fri, 15 May 2026 07:00:00 GMT
• australian biotech advancing pulmonary program adds pliant ceo as chair Stock Titan Fri, 15 May 2026 07:00:00 GMT
• oppenheimer sticks to its hold rating for pliant therapeutics (plrx) The Globe and Mail Wed, 13 May 2026 07:00:00 GMT
• number of shareholders of pliant therapeutics, inc. – mun:9pt TradingView Tue, 12 May 2026 16:27:17 GMT
• a quick look at today's ratings for pliant therapeutics(plrx.us), with a forecast between $2 to $3 Moomoo Tue, 12 May 2026 07:00:00 GMT
• ccorf downgrades pliant therapeutics(plrx.us) to hold rating, maintains target price $3 富途牛牛 Tue, 12 May 2026 07:00:00 GMT
• analyst reiterates hold on pliant therapeutics, keeps 12-month price target unchanged at $3 amid early-stage risk-reward balance TipRanks Tue, 12 May 2026 07:00:00 GMT
• pliant therapeutics provides corporate update and reports first quarter 2026 financial results markets.businessinsider.com Tue, 12 May 2026 06:54:17 GMT
• pliant therapeutics q1 net loss narrows on lower expenses TradingView Mon, 11 May 2026 21:10:04 GMT
• Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results Investing News Network Mon, 11 May 2026 07:00:00 GMT
• 8-k: pliant therapeutics provides corporate update and reports first quarter 2026 financial results - moomoo Moomoo Mon, 11 May 2026 07:00:00 GMT
• cancer pill from pliant shows responses after checkpoint drugs fail Stock Titan Mon, 11 May 2026 07:00:00 GMT
• pliant therapeutics (plrx) advances clinical trials and pipeline development GuruFocus Mon, 11 May 2026 07:00:00 GMT
• pliant therapeutics (plrx) narrows q1 2026 loss as pln-101095 shows early responses Stock Titan Mon, 11 May 2026 07:00:00 GMT
• pliant therapeutics (nasdaq: plrx) cuts q1 2026 net loss to $20m Stock Titan Mon, 11 May 2026 07:00:00 GMT
• pliant therapeutics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Mon, 11 May 2026 07:00:00 GMT
• the industry tailwinds powering pliant therapeutics (plrx) growth (smart money flows) 2026-05-08 - call spread alert newsline.com Fri, 08 May 2026 07:00:00 GMT
• plrx (pliant therapeutics) quarterly loss narrower than feared; shares tick up as pipeline hopes support sentiment. - revenue repo... The Legal Advocate Fri, 08 May 2026 07:00:00 GMT
• Pliant CEO, CFO to join RBC healthcare fireside chat on May 19 Stock Titan Wed, 06 May 2026 07:00:00 GMT
• Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference GlobeNewswire Wed, 06 May 2026 07:00:00 GMT
• plrx sec filings - pliant therapeutics, inc. 10-k, 10-q, 8-k forms Stock Titan Tue, 05 May 2026 03:54:59 GMT
• pliant therapeutics inc expected to post a loss of 36 cents a share - earnings preview TradingView Mon, 04 May 2026 11:35:06 GMT
• pliant therapeutics (nasdaq:plrx) upgraded at wall street zen MarketBeat Sun, 03 May 2026 05:17:20 GMT
• pliant therapeutics doses first participant in fortify expansion trial TipRanks Thu, 30 Apr 2026 13:42:20 GMT
• new cancer trial starts for patients after immunotherapy stops working Stock Titan Thu, 30 Apr 2026 07:00:00 GMT
• pliant therapeutics begins trial of cancer drug combination Investing.com Thu, 30 Apr 2026 07:00:00 GMT
• pliant therapeutics (plrx) initiates key clinical trial for canc GuruFocus Thu, 30 Apr 2026 07:00:00 GMT
• pliant therapeutics (plrx) price target decreased by 17.95% to 2.72 MSN Mon, 27 Apr 2026 04:49:18 GMT
• pliant therapeutics (plrx) price target decreased by 17.95% to 2.72 MSN Sun, 26 Apr 2026 09:17:21 GMT
• pliant therapeutics (plrx) price target decreased by 17.95% to 2.72 MSN Sat, 25 Apr 2026 10:03:49 GMT
• pliant therapeutics inc (fra:9pt) stock price & 30 year financial data GuruFocus Sat, 25 Apr 2026 09:07:53 GMT
• wall street zen downgrades pliant therapeutics (nasdaq:plrx) to sell MarketBeat Sat, 25 Apr 2026 07:00:00 GMT
• pliant therapeutics (plrx) price target decreased by 17.95% to 2.72 MSN Thu, 23 Apr 2026 01:33:23 GMT
• pliant therapeutics (nasdaq: plrx) outlines 2026 virtual meeting, board changes and pay vote Stock Titan Wed, 22 Apr 2026 07:00:00 GMT
• pliant therapeutics, inc. (plrx) presents at aacr annual meeting 2026 - slideshow (nasdaq:plrx) 2026-04-21 Seeking Alpha Tue, 21 Apr 2026 07:00:00 GMT
• primary sclerosing cholangitis (psc) market is expected to hit openPR.com Mon, 20 Apr 2026 07:00:00 GMT
• pliant therapeutics (plrx) reports promising updates on pln-101095 trials GuruFocus Sun, 19 Apr 2026 23:58:19 GMT
• pliant announces presentation of updated data from phase 1 trial of pln-101095 TipRanks Sun, 19 Apr 2026 07:00:00 GMT
• pliant therapeutics presents updated phase 1 data for pln-101095 in ici-refractory tumors Traders Union Sat, 18 Apr 2026 19:40:09 GMT
• pliant therapeutics : final aacr 2026 pln10195 yap marketscreener.com Sat, 18 Apr 2026 17:38:06 GMT
• pliant therapeutics announces presentation of updated data from the phase 1 trial of pln-101095 in patients with ici-refractory so... The Malone Telegram Sat, 18 Apr 2026 07:00:00 GMT
• pliant therapeutics announces board retirements and option repricing The Globe and Mail Sat, 18 Apr 2026 07:00:00 GMT
• pliant therapeutics (plrx) stock: movement analysis (breakout watch) 2026-04-18 - standard deviation newsline.com Sat, 18 Apr 2026 07:00:00 GMT
• some cancer patients stayed on pliant’s drug combo for 19 months Stock Titan Sat, 18 Apr 2026 07:00:00 GMT
• pliant therapeutics, inc. 8-k sec filing details for april 14, 2026 – company information, registered securities, and nasdaq listi... Minichart Sat, 18 Apr 2026 07:00:00 GMT
• pliant therapeutics says pln-101095 generally well tolerated; most common trae was rash, one grade 3 trae observed TradingView Sat, 18 Apr 2026 07:00:00 GMT
• pliant presents updated cancer trial data at aacr meeting Investing.com Sat, 18 Apr 2026 07:00:00 GMT
• pliant therapeutics announced that the latest data from the phase 1 clinical trial of its investigational drug pln-101095 for pati... Bitget Sat, 18 Apr 2026 02:43:31 GMT
• form 4 - statement of changes in beneficial ownership of securities ADVFN Fri, 17 Apr 2026 20:42:38 GMT
• pliant therapeutics presents updated phase 1 data for pln-101095 in ici-refractory tumors Traders Union Fri, 17 Apr 2026 19:49:44 GMT
• coo minnie kuo’s plrx options repriced to $1.33 exercise price (plrx) Stock Titan Fri, 17 Apr 2026 07:00:00 GMT
• pliant therapeutics announces board retirements and option repricing TipRanks Fri, 17 Apr 2026 07:00:00 GMT
• three pliant (nasdaq: plrx) directors to retire as options repriced Stock Titan Fri, 17 Apr 2026 07:00:00 GMT
• pliant therapeutics (nasdaq: plrx) cfo swaps options for $1.33 exercise grants Stock Titan Fri, 17 Apr 2026 07:00:00 GMT
• pliant therapeutics (plrx) reprices lily cheung stock options at $1.33 Stock Titan Fri, 17 Apr 2026 07:00:00 GMT
• pliant therapeutics (plrx) ceo resets multiple option grants to $1.33 Stock Titan Fri, 17 Apr 2026 07:00:00 GMT
• pliant therapeutics, inc. (nasdaq:plrx) given consensus recommendation of "reduce" by analysts MarketBeat Wed, 15 Apr 2026 07:00:00 GMT
• pliant therapeutics (nasdaq:plrx) shares up 1.6% - should you buy? MarketBeat Tue, 14 Apr 2026 07:00:00 GMT
• if you invested $1,000 in pliant therapeutics, inc. (plrx) Stock Titan Mon, 13 Apr 2026 14:03:50 GMT
• bull run: is pliant therapeutics inc subject to activist investor interest - 2026 catalysts & high conviction buy zone picks baoquankhu1.vn Mon, 13 Apr 2026 13:38:55 GMT
• plrx technical analysis | trend, signals & chart patterns | pliant therapeutics inc (nasdaq:plrx) ChartMill Fri, 10 Apr 2026 07:00:00 GMT
• if you invested $1,000 in pliant therapeutics, inc. (plrx) Stock Titan Wed, 08 Apr 2026 03:17:01 GMT
• pliant therapeutics, inc. (plrx) stock price prediction: today, tomorrow, next week Traders Union Mon, 06 Apr 2026 19:18:09 GMT
• is pliant therapeutics (plrx) stock lagging the market | price at $1.36, up 0.74% - momentum stock picks The Legal Advocate Mon, 06 Apr 2026 07:00:00 GMT
• live pliant therapeutics, inc. (plrx) technical analysis Traders Union Sun, 05 Apr 2026 14:52:28 GMT
• pliant therapeutics (plrx) stock analysis report | financials & insights Benzinga Japan Sun, 05 Apr 2026 04:09:42 GMT
• pliant therapeutics, inc. (plrx) stock price prediction: today, tomorrow, next week Traders Union Sat, 04 Apr 2026 06:28:24 GMT
• live pliant therapeutics, inc. (plrx) technical analysis Traders Union Sat, 04 Apr 2026 06:02:57 GMT
• if you invested $1,000 in pliant therapeutics, inc. (plrx) Stock Titan Fri, 03 Apr 2026 01:07:20 GMT
• pliant therapeutics (plrx) stock analysis report | financials & insights Benzinga Japan Wed, 01 Apr 2026 11:32:28 GMT
• plrx stock analysis: pliant therapeutics inc. gains 3.53 percent at 1.32 dollar price point newsline.com Wed, 01 Apr 2026 07:00:00 GMT
• pliant therapeutics launches new $50 million atm program The Globe and Mail Tue, 31 Mar 2026 07:00:00 GMT
• pliant’s $50m atm signals flexibility as oncology data catalyst looms in h2 2026 Bitget Tue, 31 Mar 2026 00:22:38 GMT
• pliant’s $50m atm signals flexibility as oncology data catalyst looms in h2 2026 Bitget Mon, 30 Mar 2026 08:27:51 GMT
• pliant therapeutics (nasdaq: plrx) shifts to new $50m at-the-market program Stock Titan Mon, 30 Mar 2026 07:00:00 GMT
• pliant therapeutics launches $50m at-the-market equity program, terminates prior sales agreement TradingView Mon, 30 Mar 2026 07:00:00 GMT
• pliant therapeutics (nasdaq: plrx) files $300m shelf; $50m atm with leerink Stock Titan Mon, 30 Mar 2026 07:00:00 GMT
• if you invested $1,000 in pliant therapeutics, inc. (plrx) Stock Titan Mon, 30 Mar 2026 02:49:12 GMT
• quarterly recap: is pliant therapeutics inc subject to activist investor interest - portfolio gains summary & comprehensive market... baoquankhu1.vn Sat, 28 Mar 2026 09:17:26 GMT
• pliant therapeutics (plrx) price target decreased by 17.95% to 2.72 MSN Sat, 28 Mar 2026 02:47:54 GMT
• quarterly recap: is pliant therapeutics inc subject to activist investor interest - portfolio gains summary & comprehensive market... baoquankhu1.vn Fri, 27 Mar 2026 21:16:57 GMT
• pliant therapeutics (plrx) price target decreased by 17.95% to 2.72 MSN Fri, 27 Mar 2026 12:09:21 GMT
• if you invested $1,000 in pliant therapeutics, inc. (plrx) Stock Titan Fri, 27 Mar 2026 01:02:21 GMT
• sentiment recap: is pliant therapeutics inc still a buy after recent gains - 2026 key lessons & weekly watchlist for consistent pr... baoquankhu1.vn Wed, 25 Mar 2026 16:14:54 GMT
• if you invested $1,000 in pliant therapeutics, inc. (plrx) Stock Titan Tue, 24 Mar 2026 19:14:02 GMT
Pliant Therapeutics, Inc(NASDAQ:PLRX) 
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of av6 and ...
Website: http://www.pliantrx.com
Founded: 2015
Full Time Employees: 70
CEO: Bernard Coulie
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends